276 related articles for article (PubMed ID: 19846958)
41. Radiometal-labeled somatostatin analogs for applications in cancer imaging and therapy.
Lewis JS; Anderson CJ
Methods Mol Biol; 2007; 386():227-40. PubMed ID: 18604948
[TBL] [Abstract][Full Text] [Related]
42. Recent Advances in Molecular Image-Guided Cancer Radionuclide Therapy.
Gao D; Sun X; Gao L; Liu Z
Curr Drug Targets; 2015; 16(6):634-44. PubMed ID: 26028045
[TBL] [Abstract][Full Text] [Related]
43. Advances in novel drug delivery strategies for breast cancer therapy.
Dhankhar R; Vyas SP; Jain AK; Arora S; Rath G; Goyal AK
Artif Cells Blood Substit Immobil Biotechnol; 2010 Oct; 38(5):230-49. PubMed ID: 20677900
[TBL] [Abstract][Full Text] [Related]
44. Nanotechnology for the detection and therapy of stroke.
Kyle S; Saha S
Adv Healthc Mater; 2014 Nov; 3(11):1703-20. PubMed ID: 24692428
[TBL] [Abstract][Full Text] [Related]
45. Role of lipid-soluble complexes in targeted tumor therapy.
Thakur ML; Coss R; Howell R; Vassileva-Belnikolovska D; Liu J; Rao SP; Spana G; Wachsberger P; Leeper DL
J Nucl Med; 2003 Aug; 44(8):1293-300. PubMed ID: 12902421
[TBL] [Abstract][Full Text] [Related]
46. Preparation of radioactive praseodymium oxide as a multifunctional agent in nuclear medicine: expanding the horizons of cancer therapy using nanosized neodymium oxide.
Bakht MK; Sadeghi M; Ahmadi SJ; Sadjadi SS; Tenreiro C
Nucl Med Commun; 2013 Jan; 34(1):5-12. PubMed ID: 23104000
[TBL] [Abstract][Full Text] [Related]
47. Transforming Nuclear Medicine with Nanoradiopharmaceuticals.
Roy I; Krishnan S; Kabashin AV; Zavestovskaya IN; Prasad PN
ACS Nano; 2022 Apr; 16(4):5036-5061. PubMed ID: 35294165
[TBL] [Abstract][Full Text] [Related]
48. Folate receptor-mediated drug targeting: from therapeutics to diagnostics.
Hilgenbrink AR; Low PS
J Pharm Sci; 2005 Oct; 94(10):2135-46. PubMed ID: 16136558
[TBL] [Abstract][Full Text] [Related]
49. Novel applications of nanotechnology in medicine.
Surendiran A; Sandhiya S; Pradhan SC; Adithan C
Indian J Med Res; 2009 Dec; 130(6):689-701. PubMed ID: 20090129
[TBL] [Abstract][Full Text] [Related]
50. Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICS.
Rösch F; Baum RP
Dalton Trans; 2011 Jun; 40(23):6104-11. PubMed ID: 21445433
[TBL] [Abstract][Full Text] [Related]
51. Radiolabelling of peptides for diagnosis and therapy of non-oncological diseases.
Sosabowsky J; Melendez-Alafort L; Mather S
Q J Nucl Med; 2003 Dec; 47(4):223-37. PubMed ID: 14973415
[TBL] [Abstract][Full Text] [Related]
52. Prodrugs in site-selective delivery of radiopharmaceuticals.
Baranowska-Kortylewicz J; Kortylewicz ZP; Hoffman D; Dalrymple GV
Q J Nucl Med; 1997 Jun; 41(2):127-39. PubMed ID: 9203852
[TBL] [Abstract][Full Text] [Related]
53. Lutetium-177-labeled gastrin releasing peptide receptor binding analogs: a novel approach to radionuclide therapy.
Panigone S; Nunn AD
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):310-21. PubMed ID: 17043628
[TBL] [Abstract][Full Text] [Related]
54. Bridging cancer biology and the patients' needs with nanotechnology-based approaches.
Fonseca NA; Gregório AC; Valério-Fernandes A; Simões S; Moreira JN
Cancer Treat Rev; 2014 Jun; 40(5):626-35. PubMed ID: 24613464
[TBL] [Abstract][Full Text] [Related]
55. Targeted radionuclide therapy: frontiers in theranostics.
Gallivanone F; Valente M; Savi A; Canevari C; Castiglioni I
Front Biosci (Landmark Ed); 2017 Jun; 22(10):1750-1759. PubMed ID: 28410143
[TBL] [Abstract][Full Text] [Related]
56. Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer.
D'Huyvetter M; Xavier C; Caveliers V; Lahoutte T; Muyldermans S; Devoogdt N
Expert Opin Drug Deliv; 2014 Dec; 11(12):1939-54. PubMed ID: 25035968
[TBL] [Abstract][Full Text] [Related]
57. Peptide receptor radionuclide therapy: an overview.
Dash A; Chakraborty S; Pillai MR; Knapp FF
Cancer Biother Radiopharm; 2015 Mar; 30(2):47-71. PubMed ID: 25710506
[TBL] [Abstract][Full Text] [Related]
58. Carbon nanostructures for orthopedic medical applications.
Yang L; Zhang L; Webster TJ
Nanomedicine (Lond); 2011 Sep; 6(7):1231-44. PubMed ID: 21929458
[TBL] [Abstract][Full Text] [Related]
59. Radiolabeled peptides in diagnosis and therapy.
Weiner RE; Thakur ML
Semin Nucl Med; 2001 Oct; 31(4):296-311. PubMed ID: 11710772
[TBL] [Abstract][Full Text] [Related]
60. Somatostatin analogs and radiopeptides in cancer therapy.
Froidevaux S; Eberle AN
Biopolymers; 2002; 66(3):161-83. PubMed ID: 12385036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
